http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-567816-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a319949c954315f0a8c07150ab6f11b5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2006-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e14287ff332866361b9ad989253dc414 |
| publicationDate | 2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-567816-A |
| titleOfInvention | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| abstract | Disclosed is the use of an androgenic agent in the preparation of a pharmaceutical composition for use in improving one or more side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer and having received treatment with an aromatase inhibitor. |
| priorityDate | 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 291.